1. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma
   Wei Ding et al, 2018, CBM CrossRef
2. Downregulation of circular RNA hsa_circ_0000144 inhibits bladder cancer progression via stimulating miR-217 and suppressing RUNX2 expression
   Weiping Huang et al, 2018, Gene CrossRef
3. MiR-217 promotes cell proliferation and osteogenic differentiation of BMSCs by targeting DKK1 in steroid-associated osteonecrosis
   Zhipeng Dai et al, 2019, Biomedicine & Pharmacotherapy CrossRef
4. MicroRNA‐217 relieved neuropathic pain through targeting toll‐like receptor 5 expression
   Wanwei Jiang et al, 2018, J Cell Biochem CrossRef
5. The Role of MicroRNAs in the Regulation of Gastric Cancer Stem Cells: A Meta-Analysis of the Current Status
   Vitalba Ruggieri et al, 2019, JCM CrossRef
6. Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
   null Khan et al, 2019, Cells CrossRef
7. Long noncoding‐RNA component of mitochondrial RNA processing endoribonuclease is involved in the progression of cholangiocarcinoma by regulating microRNA‐217
   Lingyu Tang et al, 2019, Cancer Sci CrossRef
8. The Emerging Roles of Cancer Stem Cells and Wnt/Beta-Catenin Signaling in Hepatoblastoma
   null Mavila et al, 2019, Cancers CrossRef
9. Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma
   Jun Liu et al, 2019 CrossRef
10. miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate Cancer
    Qingde Wa et al, 2019, Molecular Therapy - Nucleic Acids CrossRef
11. miR-219 regulates liver cancer stem cell expansion via E-cadherin pathway
    Anfeng Si et al, 2019, Cell Cycle CrossRef
12. miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo Signaling in Thyroid Cancer.
    Xiaoli Liu et al, 2019, Mol Ther Oncolytics CrossRef
13. microRNA-29a regulates liver tumor-initiating cells expansion via Bcl-2 pathway
    Shaohua Song et al, 2019, Experimental Cell Research CrossRef
14. microRNA: The Impact on Cancer Stemness and Therapeutic Resistance
    Xueqiao Jiao et al, 2019, Cells CrossRef
15. Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling
    Qingde Wa et al, 2020, Molecular Therapy - Oncolytics CrossRef
16. microRNA-4270-5p inhibits cancer cell proliferation and metastasis in hepatocellular carcinoma by targeting SATB2
    Yun Wang et al, 2020, Human Cell CrossRef
17. Noncoding RNAs: the shot callers in tumor immune escape
    Lei Liu et al, 2020, Sig Transduct Target Ther CrossRef
18. FGF9 promotes cisplatin resistance in colorectal cancer via regulation of Wnt/β‑catenin signaling pathway
    Zhijin Zhang et al, 2019, Exp Ther Med CrossRef
19. Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction
    Hajar Alemohammad et al, 2020, Life Sciences CrossRef
20. Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin
    Lubna Therachiyil et al, 2020, Front. Oncol. CrossRef
21. MicroRNA-217: A regulator of human cancer
    Shuai Zhou et al, 2021, Biomedicine & Pharmacotherapy CrossRef
22. The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis
    Xuhui Yang et al, 2021, Aging CrossRef
23. The Impact of lncRNAs and miRNAs in Regulation of Function of Cancer Stem Cells and Progression of Cancer.
    Soudeh Ghafouri-Fard et al, 2021, Front Cell Dev Biol CrossRef
24. Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy
    Dimitri Papukashvili et al, 2021, Cells CrossRef
25. MicroRNA-217: a therapeutic and diagnostic tumor marker
    Amir Abbas Hamidi et al, 2021, Expert Review of Molecular Diagnostics CrossRef
26. miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma
    Jianting Long et al, 2022, IJGM CrossRef
27. Serum level of miR-217 predicts prognostic outcome for osteosarcoma patients in China
    Lei ZHANG et al, 2022, Food Sci. Technol CrossRef
28. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities
    Zahra Asadzadeh et al, 2019, Journal Cellular Physiology CrossRef
29. Drug Discovery of DKK1 Inhibitors
    Hewen Jiang et al, 2022, Front. Pharmacol. CrossRef
30. miRNAs Inspirations in Hepatocellular Carcinoma: Detrimental and Favorable Aspects of Key Performers
    Hesham A. El-Mahdy et al, 2022, Pathology - Research and Practice CrossRef
31. The metabolic addiction of cancer stem cells
    Om Saswat Sahoo et al, 2022, Front. Oncol. CrossRef
32. MicroRNA-217 aggravates breast cancer through activation of NF1-mediated HSF1/ATG7 axis and c-Jun/ATF3/MMP13 axis
    Weihan Li et al, 2022, Human Cell CrossRef
33. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway
    Ge Wang et al, 2022, Phytomedicine CrossRef
34. The Computational Analysis of Single Nucleotide Associated with MicroRNA Affecting Hepatitis B Infection
    Mirza Ali Nazarnezhad et al, 2022, MIRNA CrossRef
35. Construction of Lentiviral Vector for miR-217 Overexpression and Knockdown and Its Effect on CML
    Xin Yang et al, 2022, Mol Biotechnol CrossRef
36. Extirpating the cancer stem cell hydra: Differentiation therapy and Hyperthermia therapy for targeting the cancer stem cell hierarchy
    Amit B. Tewari et al, 2023, Clin Exp Med CrossRef
37. In Silico Analysis of MicroRNA Expression Data in Liver Cancer
    Nourhan Abu-Shahba et al, 2023, Cancer Inform CrossRef